The NDUFA3 antibody is a valuable tool for studying the molecular composition and function of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), a critical enzyme in the electron transport chain. NDUFA3 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3) is a nuclear-encoded structural component of Complex I, which localizes to the mitochondrial inner membrane. As part of the membrane-spanning domain, NDUFA3 contributes to proton translocation and energy production via oxidative phosphorylation.
Antibodies targeting NDUFA3 are widely used in biomedical research to investigate Complex I assembly, stability, and dysfunction, particularly in diseases linked to mitochondrial disorders, such as Leigh syndrome, Parkinson’s disease, and metabolic myopathies. They enable techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein expression levels, tissue distribution, and subcellular localization.
Studies utilizing NDUFA3 antibodies have revealed its role in maintaining Complex I integrity and cellular energy homeostasis. Reduced NDUFA3 expression or mutations are associated with impaired electron transport, increased oxidative stress, and ATP depletion, highlighting its diagnostic and therapeutic relevance. Commercial availability of these antibodies from multiple suppliers has facilitated standardized research, though batch validation remains essential due to variability in mitochondrial protein detection. Overall, NDUFA3 antibodies serve as critical reagents for advancing our understanding of mitochondrial biology and related pathologies.